Skip to main content
Premium Trial:

Request an Annual Quote

DoE Awards $64M in Funding to Groups Using Genomics to Study Plants, Microbes

NEW YORK — The US Department of Energy announced on Wednesday that it has earmarked $64 million over three years to fund a series of research projects that will use genomics to study plants and microbes for bioenergy and bioproduct applications.

"We are entering an era when genomics is giving us ever greater understanding of what controls biological systems," DoE Under Secretary for Science Paul Dabbar said in a statement. "This research will help us improve crops grown for bioenergy and bioproducts, while at the same time deepening our knowledge of complex and interacting biological processes within specific environmental systems."

The microbe-focused initiatives will receive up to $35 million and will focus on the impact of microbe communities on soil nutrient cycling. Among the funding recipients are scientists from Ohio State University and the Lawrence Berkeley National Lab, who are investigating viruses in soil as modulators of microbiomes and nutrient cycling; and researchers from the University of California, Berkeley, who are looking at the role of cross-kingdom interactions in nutrient cycling in grassland soils.

The plant research projects will receive as much as $29 million to investigate gene function in plants used for fuels and other products in order to improve beneficial traits such as drought tolerance. Grant recipients include scientists from the University of California, Davis and Oak Ridge National Laboratory, who are conducting genome-wide association studies and expression quantitative trait nucleotide mapping with molecular and genetic validations to identify transcriptional networks regulating drought tolerance.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more